We are live on ! Find out more
TD Asset Management

TD Asset Management Portfolio holdings

AUM $123B
1-Year Est. Return 34.51%
This Fund
S&P 500
This Quarter Est. Return
+2.58%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$107B
AUM Growth
-$263M
Cap. Flow
-$1.18B
Cap. Flow %
-1.1%
Top 10 Hldgs %
25.85%
Holding
1,451
New
70
Increased
678
Reduced
517
Closed
90

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$291M
2
XOM icon
ExxonMobil
XOM
+$208M
3
DHR icon
Danaher
DHR
+$171M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$109M
5
NVR icon
NVR
NVR
+$108M

Sector Composition

Rank Sector Weight
1 Technology 21.93%
2 Financials 18.71%
3 Healthcare 11.45%
4 Industrials 10.26%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERX icon
1151
Vertex
VERX
$2.06B
$1.05M ﹤0.01%
+29,200
New +$940K
MSEX icon
1152
Middlesex Water
MSEX
$1.07B
$1.05M ﹤0.01%
20,128
+4,684
+30% +$243K
FUTU icon
1153
Futu Holdings
FUTU
$14.6B
$1.04M ﹤0.01%
15,884
+498
+3% +$33.7K
NE icon
1154
Noble Corp
NE
$6.7B
$1.04M ﹤0.01%
23,306
-4,020
-15% -$186K
TRDA icon
1155
Entrada Therapeutics
TRDA
$264M
$1.02M ﹤0.01%
71,308
AUR icon
1156
Aurora
AUR
$12.5B
$1.01M ﹤0.01%
365,136
+260,342
+248% +$720K
CABA icon
1157
Cabaletta Bio
CABA
$427M
$1M ﹤0.01%
134,030
+7,000
+6% +$85.8K
GFF icon
1158
Griffon
GFF
$3.99B
$990K ﹤0.01%
15,500
+6,200
+67% +$420K
ICL icon
1159
ICL Group
ICL
$6.54B
$988K ﹤0.01%
228,234
+8,261
+4% +$38.9K
ORIC icon
1160
Oric Pharmaceuticals
ORIC
$1.17B
$986K ﹤0.01%
139,400
-69,200
-33% -$619K
XPO icon
1161
XPO
XPO
$23.9B
$984K ﹤0.01%
+9,268
New +$1.04M
GH icon
1162
Guardant Health
GH
$21.3B
$983K ﹤0.01%
34,040
-78,884
-70% -$1.84M
PLAB icon
1163
Photronics
PLAB
$1.77B
$982K ﹤0.01%
39,800
+2,600
+7% +$70.5K
NVMI
1164
Nova
NVMI
$12.6B
$980K ﹤0.01%
4,176
+136
+3% +$26.9K
VGR
1165
DELISTED
Vector Group Ltd.
VGR
$977K ﹤0.01%
92,400
+24,700
+36% +$262K
IMVT icon
1166
Immunovant
IMVT
$7.84B
$972K ﹤0.01%
36,800
-32,242
-47% -$917K
TARS icon
1167
Tarsus Pharmaceuticals
TARS
$2.53B
$962K ﹤0.01%
35,388
-13,200
-27% -$444K
GBIO
1168
DELISTED
Generation Bio
GBIO
$961K ﹤0.01%
34,069
AMWD
1169
DELISTED
American Woodmark
AMWD
$959K ﹤0.01%
12,200
+800
+7% +$72.2K
RIVN icon
1170
Rivian
RIVN
$22.3B
$953K ﹤0.01%
71,032
-96,072
-57% -$1M
ANAB icon
1171
AnaptysBio
ANAB
$1.56B
$947K ﹤0.01%
37,800
+15,200
+67% +$354K
HLI icon
1172
Houlihan Lokey
HLI
$8.87B
$944K ﹤0.01%
7,000
+4,700
+204% +$615K
ANRO icon
1173
Alto Neuroscience
ANRO
$1.05B
$928K ﹤0.01%
+86,792
New +$1.13M
QLYS icon
1174
Qualys
QLYS
$5B
$927K ﹤0.01%
6,500
+4,200
+183% +$640K
SEM
1175
DELISTED
Select Medical
SEM
$926K ﹤0.01%
+48,998
New +$836K

Similar funds

TD Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, TD Asset Management held 1,451 positions worth $107B, down 0.24% from $107B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TD Asset Management's Q2 2024 filing shows 70 new, 678 increased, 517 reduced and 90 closed positions. Its largest new stake was Cooper Companies: 607,612 shares worth $53M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $215M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • TD Asset Management's largest Q2 2024 buy was Cooper Companies: 607,612 shares worth $53M.
  • TD Asset Management added most to Apple in Q2 2024, an estimated $291M increase.
  • TD Asset Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $215M.
  • TD Asset Management fully exited Hamilton Lane in Q2 2024, selling an estimated $113M.
  • TD Asset Management's ten largest holdings make up 26% of its $107B portfolio in Q2 2024.
  • TD Asset Management opened 70 new positions and closed 90 in Q2 2024.
  • TD Asset Management's portfolio value fell 0.24% quarter-over-quarter to $107B.

Based on TD Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.